Menu Close

Gene editing may enhance CAR T-cell therapy for hematologic malignancies

Researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have used gene editing technology known as CRISPR to engineer human T cells to attack certain cancers. Results from studies conducted …

Date : 2018-07-17T20:39:00.000Z
Source :

CAR T-cell therapy ‘quite promising’ for glioblastoma

Chimeric antigen receptor T-cell therapy may overcome some of the obstacles associated with systemic therapy for patients with glioblastoma, according to a review published in Neuro-Oncology. Although progress with chimeric antigen receptor (CAR) T-cell …

Date : 2018-07-17T14:08:00.000Z
Source :